Department of Radiology, Hallym University Sacred Heart Hospital, Gyeonggi-do, Korea.
Korean J Radiol. 2010 Nov-Dec;11(6):648-55. doi: 10.3348/kjr.2010.11.6.648. Epub 2010 Oct 29.
We assessed the outcomes of a simplified technique for the percutaneous placement of a hepatic artery port-catheter system for chemotherapy infusion in advanced hepatocellular carcinoma with portal vein invasion.
From February 2003 to February 2008, percutaneous hepatic artery port-catheter insertion was performed in 122 patients who had hepatocellular carcinoma with portal vein invasion. The arterial access route was the common femoral artery. The tip of the catheter was wedged into the right gastroepiploic artery without an additional fixation device. A side hole was positioned at the distal common hepatic artery to allow the delivery of chemotherapeutic agents into the hepatic arteries. Coil embolization was performed only to redistribute to the hepatic arteries or to prevent the inadvertent delivery of chemotherapeutic agents into extrahepatic arteries. The port chamber was created at either the supra-inguinal or infra-inguinal region.
Technical success was achieved in all patients. Proper positioning of the side hole was checked before each scheduled chemotherapy session by port angiography. Catheter-related complications occurred in 19 patients (16%). Revision was achieved in 15 of 18 patients (83%).
This simplified method demonstrates excellent technical feasibility, an acceptable range of complications, and is hence recommended for the management of advanced hepatocellular carcinoma with portal vein thrombosis.
评估简化技术在经皮穿刺门静脉侵犯的晚期肝细胞癌患者中进行肝动脉 PORT 导管系统化疗灌注的效果。
2003 年 2 月至 2008 年 2 月,对 122 例门静脉侵犯的肝细胞癌患者进行经皮肝动脉 PORT 导管插入术。动脉入路为股总动脉。导管尖端楔入胃网膜右动脉,无需额外的固定装置。侧孔位于肝固有动脉远端,以便将化疗药物输送到肝动脉。仅进行线圈栓塞以重新分配到肝动脉或防止化疗药物意外输送到肝外动脉。PORT 腔在腹股沟上或腹股沟下区域创建。
所有患者均获得技术成功。每次计划的化疗前均通过 PORT 血管造影检查侧孔的正确位置。19 例患者(16%)发生导管相关并发症。18 例患者中的 15 例(83%)进行了修正。
这种简化方法具有极好的技术可行性、可接受的并发症范围,因此推荐用于治疗门静脉血栓形成的晚期肝细胞癌。